EAM Global Investors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-55,297
Closed -$2.75M 205
2021
Q4
$2.75M Sell
55,297
-29,450
-35% -$1.55M 0.49% 79
2021
Q3
$3.9M Buy
84,747
+74,275
+709% +$2.94M 0.92% 18
2021
Q2
$313K Sell
10,472
-82,172
-89% -$1.68M 0.09% 141
2021
Q1
$1.88M Sell
92,644
-37,977
-29% -$801K 0.52% 111
2020
Q4
$2.18M Buy
+130,621
New +$1.72M 0.59% 94

Other funds holding ASPN

EAM Global Investors's ASPN Position: Q1 2022 in Review

EAM Global Investors sold out of Aspen Aerogels (ASPN) in Q1 2022, closing a stake of 55,297 shares — an estimated $2.75M sold.

EAM Global Investors first reported a position in ASPN in Q4 2020 and held it in 5 quarters. The position peaked at $3.9M in Q3 2021. 145 funds tracked by Wall St. Rank hold ASPN as of Q1 2022.

  • EAM Global Investors reported no remaining Aspen Aerogels position as of Q1 2022 after selling out during the quarter.
  • EAM Global Investors sold 55,297 Aspen Aerogels shares in Q1 2022, an estimated $2.75M.
  • EAM Global Investors first reported a position in Aspen Aerogels in Q4 2020 and held it in 5 quarters.
  • EAM Global Investors's Aspen Aerogels position peaked at $3.9M in Q3 2021.
  • 145 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2022.

Based on EAM Global Investors's 13F filing for Q1 2022, filed 13 May 2022.